Nuvation Bio (NUVB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.45, -6.32% vs the prior close of $4.75.
- Volume 4.47M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NUVB slides 6.3% to $4.45, a 3-month low. Closed at $4.45, -6.32% vs the prior close of $4.75. Day range $4.42–$4.75, opened at $4.75.
NUVB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NUVB slides 6.3% to $4.45, a 3-month low
- Closed at $4.45, -6.32% vs the prior close of $4.75. Day range $4.42–$4.75, opened at $4.75.
- Volume was 4.47M shares, 0.8x its 50-day average of 5.45M.
- Price is -26.1% vs its 50-day average ($6.02) and -20.0% vs its 200-day average ($5.56).
- 52-week range $3.36–$9.75; today's close sits at 17% of that range, 54.4% below the 52-week high.
Oct 15, 2026 — NUVB rises 1.5% to $4.75
- Closed at $4.75, +1.50% vs the prior close of $4.68. Day range $4.67–$4.86, opened at $4.74.
- Volume was 4.82M shares, 0.9x its 50-day average of 5.46M.
- Price is -21.5% vs its 50-day average ($6.05) and -14.9% vs its 200-day average ($5.58).
- 52-week range $3.36–$9.75; today's close sits at 22% of that range, 51.3% below the 52-week high.
Oct 14, 2026 — NUVB dips 0.8% to $4.68, a 3-month low, 3 down days in a row
- Closed at $4.68, -0.85% vs the prior close of $4.72. Day range $4.61–$4.80, opened at $4.66.
- Volume was 3.78M shares, 0.7x its 50-day average of 5.48M.
- Price is -23.1% vs its 50-day average ($6.09) and -16.5% vs its 200-day average ($5.60).
- 52-week range $3.36–$9.75; today's close sits at 21% of that range, 52.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NUVB slides 3.7% to $4.72, a 3-month low
- Closed at $4.72, -3.67% vs the prior close of $4.90. Day range $4.71–$4.92, opened at $4.86.
- Volume was 7.61M shares, 1.4x its 50-day average of 5.44M.
- Price is -22.9% vs its 50-day average ($6.12) and -16.1% vs its 200-day average ($5.63).
- 52-week range $3.36–$9.75; today's close sits at 21% of that range, 51.6% below the 52-week high.
Oct 12, 2026 — NUVB dips 2.0% to $4.90
- Closed at $4.90, -2.00% vs the prior close of $5.00. Day range $4.88–$5.01, opened at $4.96.
- Volume was 3.18M shares, 0.6x its 50-day average of 5.47M — lighter than usual.
- Price is -20.3% vs its 50-day average ($6.15) and -13.3% vs its 200-day average ($5.65).
- 52-week range $3.36–$9.75; today's close sits at 24% of that range, 49.7% below the 52-week high.
Oct 9, 2026 — NUVB rises 1.0% to $5.00
- Closed at $5.00, +1.01% vs the prior close of $4.95. Day range $4.87–$5.06, opened at $4.95.
- Volume was 2.96M shares, 0.5x its 50-day average of 5.52M — lighter than usual.
- Price is -19.1% vs its 50-day average ($6.18) and -11.9% vs its 200-day average ($5.67).
- 52-week range $3.36–$9.75; today's close sits at 26% of that range, 48.7% below the 52-week high.
Oct 8, 2026 — NUVB rises 1.9% to $4.95
- Closed at $4.95, +1.85% vs the prior close of $4.86. Day range $4.62–$4.98, opened at $4.80.
- Volume was 9.29M shares, 1.7x its 50-day average of 5.47M.
- Price is -20.3% vs its 50-day average ($6.21) and -13.1% vs its 200-day average ($5.70).
- 52-week range $3.36–$9.75; today's close sits at 25% of that range, 49.2% below the 52-week high.
Oct 7, 2026 — NUVB dips 0.4% to $4.86, a 3-month low, 6 down days in a row
- Closed at $4.86, -0.41% vs the prior close of $4.88. Day range $4.79–$4.95, opened at $4.81.
- Volume was 5.45M shares, 1.0x its 50-day average of 5.47M.
- Price is -22.2% vs its 50-day average ($6.24) and -15.0% vs its 200-day average ($5.72).
- 52-week range $3.36–$9.75; today's close sits at 23% of that range, 50.2% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — NUVB dips 1.4% to $4.88, a 3-month low, 5 down days in a row
- Closed at $4.88, -1.41% vs the prior close of $4.95. Day range $4.73–$4.97, opened at $4.96.
- Volume was 6.65M shares, 1.2x its 50-day average of 5.46M.
- Price is -22.3% vs its 50-day average ($6.28) and -15.0% vs its 200-day average ($5.74).
- 52-week range $3.36–$9.75; today's close sits at 24% of that range, 49.9% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — NUVB slides 3.7% to $4.95, a 3-month low on 1.9x normal volume
- Closed at $4.95, -3.70% vs the prior close of $5.14. Day range $4.85–$5.16, opened at $5.12.
- Volume was 9.96M shares, 1.9x its 50-day average of 5.38M — unusually heavy trading.
- Price is -21.6% vs its 50-day average ($6.32) and -14.0% vs its 200-day average ($5.76).
- 52-week range $3.36–$9.75; today's close sits at 25% of that range, 49.2% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — NUVB slides 7.6% to $5.14, a 3-month low on 2.9x normal volume
- Closed at $5.14, -7.55% vs the prior close of $5.56. Day range $5.03–$5.66, opened at $5.66.
- Volume was 14.82M shares, 2.9x its 50-day average of 5.17M — unusually heavy trading.
- Price is -19.0% vs its 50-day average ($6.35) and -11.0% vs its 200-day average ($5.78).
- 52-week range $3.36–$9.75; today's close sits at 28% of that range, 47.3% below the 52-week high.
- That makes 3 straight losses.
NUVB latest news & SEC filings
Every SEC filing by or about NUVB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hattersley Gary sold 100,000 shares at $7.09 (≈$709.00K) on Aug 19, 2026
- Hattersley Gary sold 100,000 shares at $7.09 (≈$709.00K) on Aug 19, 2026
- Hattersley Gary sold 100,000 shares at $7.09 (≈$709.00K) on Aug 19, 2026
- Hattersley Gary sold 100,000 shares at $7.09 (≈$709.00K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $31.69M (prior year $4.83M) (+555.6% vs Jun 30, 2025)
- Net income: -$62.84M (prior year -$59.01M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.17) (loss widened vs Jun 30, 2025)
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 8.01 — Reported other events the company considers important.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 8.01 — Reported other events the company considers important.
Jun 29, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 26, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 25, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Markel Stacy sold 125,000 shares at $6.03 (≈$753.75K) on Jun 23, 2026
- Markel Stacy sold 125,000 shares at $6.03 (≈$753.75K) on Jun 23, 2026
- Markel Stacy sold 125,000 shares at $6.03 (≈$753.75K) on Jun 23, 2026
- Markel Stacy sold 125,000 shares at $6.03 (≈$753.75K) on Jun 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wentworth Kerry sold 63,000 shares at $6.02 (≈$379.26K) on Jun 23, 2026
- Wentworth Kerry sold 63,000 shares at $6.02 (≈$379.26K) on Jun 23, 2026
- Wentworth Kerry sold 63,000 shares at $6.02 (≈$379.26K) on Jun 23, 2026
- Wentworth Kerry sold 63,000 shares at $6.02 (≈$379.26K) on Jun 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sauvage Philippe sold 47,668 shares at $6.01 (≈$286.48K) on Jun 23, 2026
- Sauvage Philippe sold 47,668 shares at $6.01 (≈$286.48K) on Jun 23, 2026
- Sauvage Philippe sold 47,668 shares at $6.01 (≈$286.48K) on Jun 23, 2026
- Sauvage Philippe sold 47,668 shares at $6.01 (≈$286.48K) on Jun 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade NUVB
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Mar 2, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.27% (largest 7.6%).
- Liquidity: about 5.51M shares (≈$24.51M) trade per day on average.
- 52-week position: $4.45 vs a range of $3.36–$9.75 (17% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Gary Hattersley sold 100,000 shares on Aug 19, 2026.
- Latest filings: 8-K Aug 6, 2026; 10-Q Aug 6, 2026; 8-K Jul 6, 2026.
- Share count: 351.12M shares outstanding (Aug 3, 2026), +2.6% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
NUVB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.75 | 4.75 | 4.42 | 4.45 | 4.47M |
| Oct 15, 2026 | 4.74 | 4.86 | 4.67 | 4.75 | 4.82M |
| Oct 14, 2026 | 4.66 | 4.80 | 4.61 | 4.68 | 3.78M |
| Oct 13, 2026 | 4.86 | 4.92 | 4.71 | 4.72 | 7.61M |
| Oct 12, 2026 | 4.96 | 5.01 | 4.88 | 4.90 | 3.18M |
| Oct 9, 2026 | 4.95 | 5.06 | 4.87 | 5.00 | 2.96M |
| Oct 8, 2026 | 4.80 | 4.98 | 4.62 | 4.95 | 9.29M |
| Oct 7, 2026 | 4.81 | 4.95 | 4.79 | 4.86 | 5.45M |
| Oct 6, 2026 | 4.96 | 4.97 | 4.73 | 4.88 | 6.65M |
| Oct 5, 2026 | 5.12 | 5.16 | 4.85 | 4.95 | 9.96M |
| Oct 2, 2026 | 5.66 | 5.66 | 5.03 | 5.14 | 14.82M |
| Oct 1, 2026 | 5.57 | 5.62 | 5.45 | 5.56 | 3.47M |
| Sep 30, 2026 | 5.81 | 5.82 | 5.59 | 5.60 | 5.55M |
| Sep 29, 2026 | 5.59 | 5.69 | 5.54 | 5.62 | 3.07M |
| Sep 28, 2026 | 5.68 | 5.68 | 5.48 | 5.60 | 4.58M |
| Sep 25, 2026 | 5.73 | 5.82 | 5.67 | 5.74 | 2.82M |
| Sep 24, 2026 | 5.69 | 5.78 | 5.53 | 5.73 | 5.71M |
| Sep 23, 2026 | 6.07 | 6.07 | 5.69 | 5.71 | 4.60M |
| Sep 22, 2026 | 6.26 | 6.26 | 5.95 | 6.10 | 4.32M |
| Sep 21, 2026 | 6.00 | 6.11 | 5.86 | 6.07 | 3.03M |
About Nuvation Bio
Nuvation Bio (NUVB) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1811063.
NUVB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kim D Blickenstaff | Director | May 26, 2026 |
| Robert B Bazemore | Director | May 26, 2026 |
| Xiangmin Cui | Director | May 26, 2026 |
| Kathryn E Falberg | Director | May 26, 2026 |
| David Hung | PRESIDENT AND CEO | Mar 3, 2026 |
| Robert Mashal | Director | Jun 11, 2026 |
| W Anthony Vernon | Director | May 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David C. Hanley | CHIEF TECHNICAL OPERATIONS | Mar 3, 2026 |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Aug 21, 2026 |
| David Hung | PRESIDENT AND CEO | Mar 3, 2026 |
| Dongfang Liu | CHIEF MEDICAL OFFICER | Apr 21, 2026 |
| Moses Makunje | SEE REMARKS | Mar 3, 2026 |
| Stacy Markel | CHIEF PEOPLE OFFICER | Jun 24, 2026 |
| Philippe Sauvage | Chief Financial Officer | Jul 17, 2026 |
| Colleen Sjogren | Chief Commercial Officer | Mar 3, 2026 |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | Jun 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Gary Hattersley | Sale | 100,000 | $7.09 |
| Aug 19, 2026 | Gary Hattersley | Sale | 100,000 | $7.09 |
| Aug 19, 2026 | Gary Hattersley | Sale | 100,000 | $7.09 |
| Aug 19, 2026 | Gary Hattersley | Sale | 100,000 | $7.09 |
| Jun 23, 2026 | Philippe Sauvage | Sale | 47,668 | $6.01 |
| Jun 23, 2026 | Philippe Sauvage | Sale | 47,668 | $6.01 |
| Jun 23, 2026 | Philippe Sauvage | Sale | 47,668 | $6.01 |
| Jun 23, 2026 | Philippe Sauvage | Sale | 47,668 | $6.01 |
| Jun 23, 2026 | Stacy Markel | Sale | 125,000 | $6.03 |
| Jun 23, 2026 | Stacy Markel | Sale | 125,000 | $6.03 |
| Jun 23, 2026 | Stacy Markel | Sale | 125,000 | $6.03 |
| Jun 23, 2026 | Stacy Markel | Sale | 125,000 | $6.03 |
| Jun 23, 2026 | Kerry Wentworth | Sale | 63,000 | $6.02 |
| Jun 23, 2026 | Kerry Wentworth | Sale | 63,000 | $6.02 |
| Jun 23, 2026 | Kerry Wentworth | Sale | 63,000 | $6.02 |
NUVB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $62.90M | $-204.63M | -0.60 | $-173.43M |
| Dec 31, 2024 | $7.87M | $-567.94M | -2.11 | $-130.41M |
| Dec 31, 2023 | $0 | $-75.80M | -0.35 | $-68.00M |
| Dec 31, 2022 | — | $-104.20M | -0.48 | $-96.11M |
| Dec 31, 2021 | — | $-86.85M | -0.44 | $-68.19M |
Latest balance sheet: total assets $744.50M, total liabilities $490.64M, cash $258.60M (as of Jun 30, 2026).
NUVB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $6.11 |
| May 4, 2026 | 8-K Item 2.02 (results) | $4.41 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $5.84 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $6.46 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $5.17 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.34 |
| May 7, 2025 | 8-K Item 2.02 (results) | $2.04 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $1.89 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $2.54 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NUVB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.